… profiles of the pharmaceutical companies that are … Trials: > 2300 Drugs In Trials Commercially Available Cancer Immunotherapies: > 120 Cancer Vaccines … during cancer immunotherapy treatment resulting in higher … -2b) 20.4 Sylatron (Peginterferon Alpha-2b) …

… ) - Ipilimumab (Yervoy) - PegIntron (Sylatron) - Proleukin (Aldesleukin) - Pembrolizumab … Immunotherapeutic agents for melanoma - Vaccines for melanoma - Genetic therapies … for melanoma treatment What issues will affect the melanoma drugs market? Our …

… methods such as vaccine and immunotherapy. The recent FDA approvals of six … 5 Peginterferon alpha 2-b (Sylatron) 5.4.6 Interleukin- … 5 Inhibitors in Malignant Melanoma Treatment 5.5.1 Vemurafenib ( … 5 Chiron 14.6 Enzon Pharmaceuticals 14.7 GlaxoSmithKline 14.8 …

… area of high unmet medical need, especially in … ® package inserts. 2 SYLATRON Prescribing Information Full Year … across multiple treatment modalities including antibody-drug conjugates (“ADCs … and successfully complete clinical trials, including the ongoing …

… -scale production of pharmaceutical-grade proteins and the … the biological performance of biotech drugs. In: Van Der … to conventional treatment: two randomized controlled trials. JAMA. … 47;www.fda.gov/files/vaccines,%20blood%20%26%20biologics…